MRK  Merck & Company Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

166.1B

Vuru Grade

45.77/100

Current Price

$56.47
+0.21 (+0.37%)

Growth Price

$40.86
Overvalued by 27.65%

Stability Price

$17.49
Overvalued by 69.03%

Company Metrics

  • 38.27 P/E
  • 3.76 P/S
  • 3.31 P/B
  • 1.47 EPS
  • 13.83% Cash ROIC
  • 0.92 Cash Ratio
  • 1.74 / 3.09% Dividend
  • 12.50M Avg. Vol.
  • 2.94B Shares
  • 166.1B Market Cap.

Company Description

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company's Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, ...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

There is no news available at this time.